Nucleic acid therapies: Towards cardiac-specific recombinant adeno-associated viruses (rAAVs) of human origin: Directed evolution and characterization of novel AAV variants isolated from human failing hearts in models with human relevance and relevance fo


Förderkennzeichen

81X2500195

Projektnummer

1326

Institution
Universität Heidelberg
Projektleiter
Patrick Most
Standort
Heidelberg/Mannheim
Projektart
Innovation Cluster
Fördersumme
€ 607.835,00
Beginn
01.01.2021
Ende
31.12.2024
Partnerprojekte